课题基金 / 基金详情

Determinants of Self-Renewal, Differentiation, and Reprogramming of hESCs

Determinants of Self-Renewal, Differentiation, and Reprogramming of hESCs
hESC 自我更新、分化和重编程的决定因素
批准号:
8338841
负责人:
James Alexander Thomson
金额:
$166.1万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2014-07-31

项目摘要

项目成果

James Alexander Thomson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (provided by applicant): Understanding how human embryonic stem (ES) cells can proliferate without limit and yet retain the ability to differentiate to any cell type is the theme that links the three individual projects of this proposal. Project 1 will identify novel histone modifications in human ES cells using a new mass spectrometry technique that allows an unprecedented ability to identify and map posttranslational protein modifications. Histone modifications in human ES cells will be identified globally, at promoters, and at select genes directly regulated by critical pluripotency factors. We will also examine the role of histone H3 variants in establishing long-term epigenetic memory. These studies will determine whether there is a novel histone code in pluripotent cells and determine how histone modifications change dynamically during differentiation. Project 2 examines the critical events that occur in the window of time during which human ES cells commit eprogram differentiated cells to a pluripotent state. We have previously reported that when myeloid cells are fused with human ES cells, the myeloid nucleus is reprogrammed to an ES cell state, indicating that transacting factors in ES cells are sufficient to mediate nuclear reprogramming. Our preliminary results suggest that over expressing combinations of human ES cell-enriched genes can reprogram myeloid cells, and this project will optimize this reprogramming. The combination of these projects will provide an increased understanding of the pluripotent state and the basic processes by which a cell can leave or return to that state. Such an understanding will be important to transplantation and regenerative medicine. Lay Description: Human ES cells are special because they can grow without limit and can give rise to all other cell types. Here we will try to understand why human ES cells have this remarkable developmental potential, and develop conditions to convert a cell with a more limited potential to an ES cell. Such reprogramming has implications for transplantation and regenerative medicine.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s13361-013-0701-2
发表时间: 2013-11
期刊: JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
影响因子: 3.2
作者: [Frey, Brian L., Ladror, Daniel T., Sondalle, Samuel B., Krusemark, Casey J., Jue, April L., Coon, Joshua J., Smith, Lloyd M.]
通讯作者: Smith, Lloyd M.
DOI: 10.1016/j.stemcr.2013.12.005
发表时间: 2014-01-14
期刊: STEM CELL REPORTS
影响因子: 5.9
作者: [Brumbaugh, Justin, Russell, Jason D., Yu, Pengzhi, Westphall, Michael S., Coon, Joshua J., Thomson, James A.]
通讯作者: Thomson, James A.
The Formation and Stability of Alkylthiol Monolayers on Carbon Substrates.
碳基底上烷基硫醇单层的形成和稳定性。
DOI: 10.1021/jp102821x
发表时间: 2010
期刊: The journal of physical chemistry. C, Nanomaterials and interfaces
影响因子: --
作者: [Lockett,MatthewR, Smith,LloydM]
通讯作者: Smith,LloydM
DOI: 10.1016/j.stem.2011.01.001
发表时间: 2011-03-04
期刊: Cell stem cell
影响因子: 23.9
作者: [Yu P, Pan G, Yu J, Thomson JA]
通讯作者: Thomson JA
12
    Transplantation of MHC Homozygous Vascular Progenitors in Primates
    Transplantation of MHC Homozygous Vascular Progenitors in Primates
    Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and Teratogenicity
    Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and Teratogenicity
    国内基金
    海外基金
    分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
    CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
    • 批准号:
      82072862
    • 项目类别:
      面上项目
    • 资助金额:
      56.0万元
    • 批准年份:
      2020
    • 负责人:
      徐云升
    • 依托单位:
    S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
    • 批准号:
      82070825
    • 项目类别:
      面上项目
    • 资助金额:
      53.0万元
    • 批准年份:
      2020
    • 负责人:
      徐西振
    • 依托单位:
    Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
    • 批准号:
      81903002
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.5万元
    • 批准年份:
      2019
    • 负责人:
      王斐斐
    • 依托单位: